文献速递医院感染防控细菌感染、耐药与抗菌药物

强化感染防控与抗菌药物管理对难辨梭菌、耐万古霉素肠球菌及第三代头孢菌素耐药肠杆菌感染的影响:阶梯楔形整群干预研究

Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study.
PubMed 文献 · Clin Microbiol Infect · 2025-08-23

该研究在5家德国大学医院15个科室开展阶梯楔形整群干预,评估强化感染防控(IPC)与抗菌药物管理(AMS)对难辨梭菌感染(CDI)及耐万古霉素肠球菌(VRE)和第三代头孢菌素耐药肠杆菌(3GCREB)血流感染(BSI)的影响。结果显示强化AMS后CDI发病率密度显著下降,而VRE/3GCREB BSI无相关变化。

要点

  • 强化AMS措施后CDI发病率密度显著降低。
  • VRE/3GCREB血流感染发病率密度无相关变化。
  • 在IPC与AMS基线成熟的低发病率机构,联合干预效果有限。

核心结论

  • 在IPC基础上强化短期AMS措施可显著降低CDI发病率,但VRE和3GCREB血流感染发病率无变化。

研究设计与样本

  • 在5家德国大学医院15个科室开展阶梯楔形整群干预研究,纳入超过384,000患者日。
  • 采用中断时间序列分析评估干预效果。

主要发现

  • 目标感染发病率密度低:CDI为0.77/1000患者日,VRE BSI为0.07/1000患者日,3GCREB BSI为0.09/1000患者日。
  • 强化AMS后CDI发病率密度显著下降(回归斜率差-0.089;F[p]=5.400[0.037])。
  • VRE/3GCREB BSI发病率密度无相关变化(回归斜率差-0.19;F[p]=0.667[0.429])。
  • 血液肿瘤科室亚组分析显示AMS影响处方行为但未影响临床结局。

临床怎么用

  • 在IPC基础上强化短期AMS措施可降低CDI发病率。
  • 对VRE和3GCREB BSI的预防需考虑其他策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Infection prevention and control (IPC) and antimicrobial stewardship (AMS) measures are critical to reducing transmission and infection by Clostridioides difficile (CDI) and other enteric pathogens. This study evaluated the impact of enhanced IPC and AMS on CDI and bloodstream infections (BSIs) caused by vancomycin-resistant enterococci (VRE) and third-generation cephalosporin-resistant Enterobacterales (3GCREB). METHODS: The study was conducted in five German university hospitals from January 2016 to July 2019. IPC and AMS interventions were sequentially enhanced in three departments with high-incidence CDI at baseline using a stepped-wedge cluster intervention approach. Main outcome measures were incidence densities of CDI and BSI caused by VRE and 3GCREB. An interrupted time series analysis was performed to assess the intervention effects during a normalized study period. RESULTS: Across 15 departments, >384,000 patient days were included. Incidence density of target infections was low (CDI, 0.77; VRE BSI, 0.07; and 3GCREB BSI, 0.09 per 1000 patient days). Pooled interrupted time series analysis results showed a significant reduction in CDI incidence density following the enhancement of AMS measures (AMS period regression slopes difference, -0.089; F[p] = 5.400 [0.037]). Regarding the incidence density of VRE/3GCREB BSI, no relevant changes could be observed (regression slopes difference, -0.19; F[p] = 0.667 [0.429]). A subgroup analysis focusing on haematological and oncological departments showed that AMS influenced prescription behaviour according to implemented AMS strategies, but not clinical outcomes. DISCUSSION: Combined with IPC enhanced short-term AMS measures led to a significant reduction in the incidence of CDI, whereas the incidence of BSI by VRE and 3GCREB remained unchanged in sites with well-established baseline IPC and AMS programmes and low incidence of hospital-associated infections.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Classen AY, Dietz T, Graeff LD, et al. Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study. Clin Microbiol Infect. 2025. PMID: 40854464. doi:10.1016/j.cmi.2025.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。